重组Anti-PDE4D抗体[EPR11823-31]
Anti-PDE4D antibody [EPR11823-31]
- RabMAb
- Recombinant
- 了解详情
4
(1 Review)
|
(17 Publications)
Rabbit Recombinant Monoclonal PDE4D antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications.
查看别名
DPDE3, PDE4D, PDE43, cAMP-specific phosphodiesterase 4D
- WB
Supplier Data
Western blot - Anti-PDE4D antibody [EPR11823-31] (AB171750)
All lanes:
Western blot - Anti-PDE4D antibody [EPR11823-31] (ab171750) at 1/1000 dilution
Lane 1:
Human fetal heart lysate at 10 µg
Lane 2:
Human fetal brain lysate at 10 µg
Predicted band size: 91 kDa
false
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯度
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDE4D plays an important role in the modulation of intracellular cAMP levels impacting processes such as inflammation cognition and cardiac function. It does not operate as part of a larger complex but collaborates with other signaling molecules to influence cellular responses. PDE4D's regulation of cAMP levels directly affects protein kinase A (PKA) leading to alterations in gene expression and cell activity.
Pathways
PDE4D integrates into the cAMP signaling and inflammatory pathways impacting various cellular responses. In the cAMP signaling pathway it partners with other PDEs and signaling proteins such as PKA which phosphorylates target proteins affecting cellular function. In inflammatory pathways PDE4D modulates immune cell activity by altering the cAMP-mediated inhibition of pro-inflammatory cytokine production linking it to inflammation-related responses.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (17)
Recent publications for all applications. Explore the full list and refine your search
Clinical and translational medicine 15:e70189 PubMed39956959
2025
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 292:3360-3377 PubMed39673076
2024
Applications
Unspecified application
Species
Unspecified reactive species
The international journal of neuropsychopharmacology 27: PubMed39099166
2024
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 9:74 PubMed38528022
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular research 120:273-285 PubMed38099489
2023
Applications
Unspecified application
Species
Unspecified reactive species
ESC heart failure 11:541-549 PubMed37964758
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed36291124
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 54:1201-1213 PubMed35999453
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 13:933963 PubMed35837016
2022
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 179:4078-4091 PubMed35362097
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com